Urine test to check TB medication use
Part of Infections, Lungs & breathing clinical trials.
This study checks a simple urine test to see if people with TB are taking their medication (isoniazid) regularly. It aims to help doctors find out sooner if someone is missing doses, so they can offer extra support.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have or are suspected to have drug-sensitive TB in your lungs (this includes people who have had TB before).
- You are currently taking a TB treatment that includes a medicine called isoniazid.
- You are able to understand and agree to take part in the study.
- You do not have drug-resistant TB and you have not switched to a TB treatment without isoniazid.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how a simple blood test can help monitor tuberculosis (TB) treatment. It may help doctors know sooner if the treatment is working.
This trial tests inhaled isoniazid (medicine) given through a nebulizer to see how well it works and how safe it is. It's for people being treated for tuberculosis.
This study looks at how often the TB drug isoniazid causes liver problems and what factors might predict them. It could help doctors monitor your liver health more safely if you are being treated with isoniazid.
This study tests if taking the TB prevention medicine isoniazid is safe for people with lupus (SLE). It may help protect you from getting tuberculosis while managing your lupus.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This study tests whether giving a personalized dose of rifampin (a key TB medicine) can improve treatment. It is for people with active TB that is sensitive to rifampin, and it involves frequent blood and urine tests to measure drug levels.
Hear when a new Tuberculosis, Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.